Literature DB >> 9549453

Association between plasma concentrations of plasminogen activator inhibitor-1 and survival in patients with colorectal cancer.

H J Nielsen1, H Pappot, I J Christensen, N Brünner, O Thorlacius-Ussing, F Moesgaard, K Danø, J Grøndahl-Hansen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9549453      PMCID： PMC28485          DOI： 10.1136/bmj.316.7134.829

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  5 in total

Review 1.  Plasminogen activator inhibitors: hormonally regulated serpins.

Authors:  P A Andreasen; B Georg; L R Lund; A Riccio; S N Stacey
Journal:  Mol Cell Endocrinol       Date:  1990-01-02       Impact factor: 4.102

Review 2.  Plasminogen activators, tissue degradation, and cancer.

Authors:  K Danø; P A Andreasen; J Grøndahl-Hansen; P Kristensen; L S Nielsen; L Skriver
Journal:  Adv Cancer Res       Date:  1985       Impact factor: 6.242

3.  Plasminogen activators and plasminogen activator inhibitors in blood and tumour fluids of patients with ovarian cancer.

Authors:  B Casslén; T Bossmar; I Lecander; B Astedt
Journal:  Eur J Cancer       Date:  1994       Impact factor: 9.162

4.  High levels of urokinase-type plasminogen activator and its inhibitor PAI-1 in cytosolic extracts of breast carcinomas are associated with poor prognosis.

Authors:  J Grøndahl-Hansen; I J Christensen; C Rosenquist; N Brünner; H T Mouridsen; K Danø; M Blichert-Toft
Journal:  Cancer Res       Date:  1993-06-01       Impact factor: 12.701

5.  Specificity of antigen assays of plasminogen activator inhibitor in plasma: Innotest PAI-1 immunoassay evaluated.

Authors:  P Meijer; D E Pollet; J Wauters; C Kluft
Journal:  Clin Chem       Date:  1994-01       Impact factor: 8.327
  5 in total
  16 in total

1.  Prognostic value of PAI1 in invasive breast cancer: evidence that tumor-specific factors are more important than genetic variation in regulating PAI1 expression.

Authors:  Mark D Sternlicht; Alison M Dunning; Dan H Moore; Paul D P Pharoah; David G Ginzinger; Koei Chin; Joe W Gray; Frederic M Waldman; Bruce A J Ponder; Zena Werb
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-11       Impact factor: 4.254

2.  Association between plasma plasminogen activator inhibitor-1 and survival in colorectal cancer. Measuring C reactive protein concentrations may be more useful.

Authors:  N Sattar; D C McMillan
Journal:  BMJ       Date:  1998-09-12

3.  Proteases as prognostic markers in cancer.

Authors:  H W Verspaget
Journal:  BMJ       Date:  1998-03-14

Review 4.  Plasminogen activator inhibitor-1 (PAI-1): a key factor linking fibrinolysis and age-related subclinical and clinical conditions.

Authors:  Matteo Cesari; Marco Pahor; Raffaele Antonelli Incalzi
Journal:  Cardiovasc Ther       Date:  2010-07-07       Impact factor: 3.023

Review 5.  The molecular biology of colorectal cancer development and the associated genetic events.

Authors:  R M Navaratnam; J Chowaniec; M C Winslet
Journal:  Ann R Coll Surg Engl       Date:  1999-09       Impact factor: 1.891

6.  Plasminogen activator system, vascular endothelial growth factor, and colorectal cancer progression.

Authors:  E A Baker; F G Bergin; D J Leaper
Journal:  Mol Pathol       Date:  2000-12

7.  ARNTL2 and SERPINE1: potential biomarkers for tumor aggressiveness in colorectal cancer.

Authors:  Gianluigi Mazzoccoli; Valerio Pazienza; Anna Panza; Maria Rosa Valvano; Giorgia Benegiamo; Manlio Vinciguerra; Angelo Andriulli; Ada Piepoli
Journal:  J Cancer Res Clin Oncol       Date:  2011-12-24       Impact factor: 4.553

8.  In vitro evaluation of anticancer properties of exopolysaccharides from Lactobacillus acidophilus in colon cancer cell lines.

Authors:  Venkataraman Deepak; Sharavan Ramachandran; Reham Mohammed Balahmar; Sureshbabu Ram Kumar Pandian; Shiva D Sivasubramaniam; Hariharan Nellaiah; Krishnan Sundar
Journal:  In Vitro Cell Dev Biol Anim       Date:  2015-12-10       Impact factor: 2.416

9.  A novel discriminant score based on tumor-associated trypsin inhibitor for accurate diagnosis of metastasis in patients with breast cancer.

Authors:  Hatem A El-mezayen; Fatheya M Metwally; Hossam Darwish
Journal:  Tumour Biol       Date:  2013-11-13

10.  Changed adipocytokine concentrations in colorectal tumor patients and morbidly obese patients compared to healthy controls.

Authors:  Andreas Hillenbrand; Juliane Fassler; Nadine Huber; Pengfei Xu; Doris Henne-Bruns; Markus Templin; Hubert Schrezenmeier; Anna Maria Wolf; Uwe Knippschild
Journal:  BMC Cancer       Date:  2012-11-23       Impact factor: 4.430
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.